GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Allergan Plc (AGN) [hlAlert]

Rating:
Buy ACT
up 509.13 %

Actavis Inc. (ACT) rated Buy with price target $333 by UBS

Posted on: Tuesday,  Nov 18, 2014  1:25 PM ET by UBS

UBS rated Buy Allergan Plc (NYSE: AGN) on 11/18/2014. Previously UBS rated Buy Allergan Plc (NYSE: AGN) on 11/05/2010., when
the stock price was $51.22. Since then, Allergan Plc has gained 509.14% as of 11/24/2015's recent price of $312.00.
If you would have followed the previous UBS's recommendation on AGN, you would have gained 509.13% of your investment in 1845 days.

Watson Pharmaceuticals, Inc. (Watson) is a specialty pharmaceutical company engaged in the development, manufacture, marketing, sale and distribution of brand and generic (off-patent) pharmaceutical products. Watson operates and manages its business as three operating segments: Generic, Brand and Distribution. As of December 31, 2008, the Company marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families through its generic and brand divisions, respectively, and distributed approximately 8,000 stock-keeping units (SKUs) through its distribution division. The Company?s operations are based predominantly in the United States and India, with its key commercial market being the United States. In July 2008, Watson and Mylan Inc. announced that Mylan Inc. has acquired Watson?s 50% interest in the Somerset Pharmaceuticals, Inc. joint venture. In December 2009, the Company completed the acquisition of Arrow Group.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/18/2014 1:25 PM Buy
None
267.20 333.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/19/2014 12:25 PM Buy
None
210.50 237.00
5/30/2013 11:25 AM Buy
None
125.43 155.00
5/3/2013 10:25 AM Buy
None
106.74 120.00
4/26/2012 12:25 PM Buy
None
73.86 80.00
3/11/2011 12:25 PM Buy
None
56.92 69.00
2/16/2011 1:33 PM Buy
None
56.36 64.00
11/5/2010 12:25 PM Buy
None
51.22 59.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy